Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Getting to be time to move them again.
Grape fruit growers are going to celebrate on the day of TLD.
Like a Friday afternoon document dump.
Looks like you think approval by an RA is quite possible and in the works.
This is a pre-emptive FUD strike.
Thanks for the education, Bob_Loblaw. Appreciate it.
Any possibiity that, as speculated, if NWBO and Merck have been working on a deal in the background, the first announcement out of the gate is a buyout PR with the amount? That would have the benefit of establishing a floor for the SP and closes the gates on any escape routes or avenues for people like AF to try and create havoc. The journal and TLD could follow right after.
Need Roundup - Journal+TLD.
Wasn't Stupp consulting with NWBO in 2019?
But does 'These therapies' refer solely to DCVAX or 'personalized immunotherapies'? Even though the statement says that they are developing DCVaz persolized immunotherapies, the statement could be construed to be about personalized immunotherapies as DCVax is one of them. If so, then 'it' (NWBO) is making a positive statement about immunotherapies in general and not DCVAx in particular.
In response to a message trail about teh SAP and FDA's lack of response within 30 days you said:
All we know for a fact is that the FDA did not send LL the notice that the IND change would be placed on hold because of patient safety concerns. Like duh.
Thank you for all your efforts in setting up and maintaining this valuable resource for the NWBO community.
I also recall the head of the DMC issuing a very emphatic statement refuting claims by various bloggers and others that an IA had been conducted and did not show any efficacy.
Specious argument as NWBO could not really do it in advance of their trial could they? They did do it as soon as feasible in their situation and it was before data lock.
So, I have been wondering, is there any reg that says that they cannot file a BLA befoe releasing TLD? I realize that historically, that is what Pharmas and Biotechcs have done, but is there anything from the FDA that requires a TLD before a BLA filing?
Or is it a pre-emptive mea culpa to salvage his reputation?
Thank you for continuing to connect the dots and document the progression and progress.
Arya, aka NWBO, is coming for the 'night king of biotech'.
Do you see that little circle with an R inside next to the word DCVAX?
AF crawls into his hole to never be heard from again.
Could the impending news of this have been the reason for yesterday's selloff?
The tried and true early session slam...
Hi Sojo,
I must say your posts are like a warm blanket on a cold day.
DocLogic,
True. Unfortunately, for the present, it continues to be a long night.
None of their competitors and in fact the whole industry did anything remotely close to what they do over the last few decades. They faced a ton of challenges early on in their journey and there were a ton of skeptics! If it were up to you, these companies are fraud and do not deserve to be successful?
Would it then be correct to assume that DCVAX-L has a greater benefit than current SOC, if the results of the trials used to establish that SOC were to be re-calculated (if possible) based on this revised definition of GBM? So, the previously stated PFS of 19.4 months for the Stupp protocol could actually be lower.
I recall that, sometime last year, he also posted inaccurate and confused analysis/opinion regarding NWBO on Seeking Alpha.
https://seekingalpha.com/article/4328827-northwest-biotherapeutics-dcvaxs-path-to-statistical-significance-remains-mystery?source=content_type%3Areact%7Csection%3AAll%7Csection_asset%3AAnalysis%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A5
https://seekingalpha.com/article/4321633-northwest-biotherapeutics-great-science-poor-investment-idea?source=content_type%3Areact%7Csection%3AAll%7Csection_asset%3AAnalysis%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A6
https://help.streetsmart.schwab.com/Com/3.44/Content/Trade_Stocks.htm
Not sure why it would trigger since the SP went up yesterday. Likely a glitch during Schwab's updates. Or a weak attempt at FUD.
Corning glass might realize the sale of the company was the biggest mistake they ever made.
I figured this bear raid was going to happen when AVII popped up on this board over the weekend.
LP said no TLD at ASCO. So, doesn't that leave open the possibility that there may be some other announcement during ASCO or soon thereafter?
Nice close. Last I checked this morning, we were down 0.06 or so. The volume if up as well, compared to the last 2 days or so. Overall, steady as she goes!
Doc Logic,
Why are you expecting CRL's spring update to be significant for NWBO? They could have other initiatives in progress to report on in their spring update.
Now that you mention it, I seem to recall that as well. I am pretty sure the more knowledgeable posters like Flipper, Senti, DocLogic, et al., will have a more definitive answer as well as references.
Looks like the predicted retracement to 1.79 happened and did it today.
Swegen, consider me interested.
3 dojis and buyout. ....oops. Breakout.
Thanks. So payment to be submitted and formalities to be completed to get the patent officially issued. Wonderful.
Is Notice of Allowance equivalent to approval or granting the patent?
Right now it is heading towards where we started. Someone with minions needs to pitch in.